As head of the Division of Applied Regulatory Science at the US Food and Drug Administration (FDA), David Strauss, MD, PhD, has the unique role of ushering innovative research into the agency’s drug review process. For example, his division’s work includes analyzing drugs’ chemical structure to anticipate rare adverse events, like cancer or liver failure, that often go undetected during clinical trials.
“We take on projects that aren’t being addressed by others in the scientific community,” he said during a recent interview. Unanswered questions surrounding consumer products, like sunscreen, also fall under his purview. Over the past year, his team has published 2 clinical trials in JAMA on sunscreen absorption in the blood.
Abbasi J. FDA Trials Find Sunscreen Ingredients in Blood, but Risk Is Uncertain. JAMA. 2020;323(15):1431–1432. doi:10.1001/jama.2020.0792
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: